Yada Noritaka, Fujioka Masayuki, Bennett Charles L, Inoki Kazuya, Miki Toyokazu, Watanabe Akihiko, Yoshida Toshiko, Hayakawa Masaki, Matsumoto Masanori, Fujimura Yoshihiro
Department of Emergency and Critical Care Medicine, Yodogawa Christian Hospital Osaka, Japan.
Department of Emergency and Critical Care Medicine, Nara Medical University Kashihara, Japan.
Clin Case Rep. 2015 Apr;3(4):208-12. doi: 10.1002/ccr3.196. Epub 2015 Feb 2.
We report a 14-year-old girl, who developed shigatoxin-producing E. coli (STEC)-HUS complicated by encephalopathy. She was successfully treated with hemodiafiltration, high-dose methylprednisolone pulse therapy, and soluble recombinant thrombomodulin under plasma exchange. von Willebrand factor multimers analysis provides potential insights into how the administered therapies might facilitate successful treatment of STEC-HUS.
我们报告了一名14岁女孩,她患上了产志贺毒素大肠杆菌(STEC)-溶血尿毒综合征,并伴有脑病。她在血浆置换的情况下,通过血液透析滤过、大剂量甲泼尼龙冲击疗法和可溶性重组血栓调节蛋白成功得到治疗。血管性血友病因子多聚体分析为所给予的治疗方法如何促进STEC-溶血尿毒综合征的成功治疗提供了潜在的见解。